Fisher & Paykel Healthcare Corporation Limited Share Price Deutsche Boerse AG

Equities

FPLB

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Delayed Deutsche Boerse AG 07:04:51 15/05/2024 BST 5-day change 1st Jan Change
15.7 EUR 0.00% Intraday chart for Fisher & Paykel Healthcare Corporation Limited -0.63% +18.94%

Financials

Sales 2024 * 1.73B 1.06B 973M 83.57B Sales 2025 * 1.94B 1.19B 1.09B 93.68B Capitalization 16.67B 10.17B 9.36B 804B
Net income 2024 * 257M 157M 144M 12.39B Net income 2025 * 331M 202M 186M 15.96B EV / Sales 2024 * 9.72 x
Net Debt 2024 * 179M 109M 101M 8.65B Net Debt 2025 * 235M 143M 132M 11.33B EV / Sales 2025 * 8.7 x
P/E ratio 2024 *
64.7 x
P/E ratio 2025 *
49.8 x
Employees -
Yield 2024 *
1.38%
Yield 2025 *
1.5%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 week-0.63%
Current month+1.95%
1 month+9.79%
3 months+18.94%
6 months+33.05%
Current year+18.94%
More quotes
1 week
15.60
Extreme 15.6
15.90
1 month
14.30
Extreme 14.3
15.90
3 years
10.20
Extreme 10.2
20.20
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 31/12/84
Director of Finance/CFO - 28/02/19
Chief Tech/Sci/R&D Officer - 31/12/06
Members of the board TitleAgeSince
Director/Board Member 66 30/04/90
Chairman - 30/09/15
Chief Executive Officer 63 31/12/84
More insiders
Date Price Change
15/05/24 15.7 0.00%
14/05/24 15.7 +0.64%
13/05/24 15.6 -1.27%
10/05/24 15.8 +0.64%
09/05/24 15.7 -1.26%

Delayed Quote Deutsche Boerse AG, May 15, 2024 at 07:04 am

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
28.8 NZD
Average target price
24.49 NZD
Spread / Average Target
-14.98%
Consensus